è¿60å¹´æ¥ï¼å¯¹å¿è¡ç®¡ç¾ç
å±é©å ç´ ç综åæ§å¶åå¾äºæ¾èææãç¶èï¼å¯¹äºå¿è¡ç®¡ç
ã2åç³å°¿ç
å代谢综åå¾æ£è
ï¼å¨ä½å¯åº¦èèç½èåºéï¼LDL-Cï¼ãè¡åãè¡ç³çä¼ ç»å±é©å ç´ æ§å¶è¾¾æ åï¼æ£è
大è¡ç®¡äºä»¶ï¼å¿èæ¢æ»ãèåä¸ï¼ä»¥åå¾®è¡ç®¡äºä»¶ï¼è§ç½èç
åãè¾èç
ååå¨å´ç¥ç»ç
åï¼åççä»ç¶è¾é«ï¼ç»ç§°ä¸ºå¿è¡ç®¡å©çé£é©ãå æ¤ï¼å¨æ§å¶ä¼ ç»å±é©å ç´ çåæ¶ï¼å¯¹å¿è¡ç®¡å©çé£é©è¿è¡å¹²é¢å管çï¼ææè¿ä¸æ¥éä½å¿è¡ç®¡äºä»¶ã
ççé£äºå©ä½çå¿è¡ç®¡é£é©å§ï¼
è¡èå¼å¸¸çå¿è¡ç®¡å±é©é¤äºä¸LDL-Cç¸å
³ä¹å¤ï¼è¿ä¸é«çæ²¹ä¸é
¯ï¼TGï¼æ°´å¹³ä»¥åé«å¯åº¦èèç½èåºéï¼HDL-Cï¼ç¸å
³ãå¨2åç³å°¿ç
å代谢综åå¾æ£è
ä¸ï¼é«TGåä½HDL-C常伴éåå¨ï¼è¿ç§ç¹å¾çè¡èå¼å¸¸è¢«ç§°ä¸ºè´å¨è粥硬åæ§è¡èå¼å¸¸ï¼æ¯ä»æ±ç±»è¯ç©éä½LDL-Cåï¼å¿è¡ç®¡å©çé£é©ä¸çéè¦å ç´ ã
é«çæ²¹ä¸é
¯è¡çè´å¨èç²¥æ ·ç¡¬åè¡èå¼å¸¸çä½ç¨æºå¶
é«çæ²¹ä¸é
¯æ¯è´å¨èç²¥æ ·ç¡¬åæ§è¡èå¼å¸¸ç
çççæºå¶ä¸çæ ¸å¿å ç´ ãé«çæ²¹ä¸é
¯è¡çè´å¨èç²¥æ ·ç¡¬åå¯è½ä¸å°èå¯LDLï¼sLDLï¼å¢å¤ãæä½å¯åº¦èèç½ï¼VLDLï¼æ®ç²å¢å ãä¹³ç³å¾®ç²æ®ç²å¢å 以åHDL-Céä½ï¼åè¡çº¤æº¶ç³»ç»æ¹åçå ç´ æå
³ã
å½TGï¼1.70mmol/Læ¶ï¼å
·æè¾å¼ºè´å¨èç²¥æ ·ç¡¬åä½ç¨çsLDLæ°´å¹³åé«ï¼è大é¢ç²HDLå«éåå°ï¼å
·ææå¨èç²¥æ ·ç¡¬åä½ç¨çHDLæç代谢è¿ç¨åé»ã
sLDLé¾è¢«LDLåä½è¯å«ï¼ç»æ£å¸¸éå¾æ¸
é¤ä¸å
åï¼ä¸sLDLæ被氧åæå
·æå
ç®æ¯æ§çæ°§åä½å¯åº¦èèç½ï¼oxLDLï¼ï¼ä¼å
被巨å¬ç»èåå¬å为泡沫ç»èï¼ææå¨èç²¥æ ·çèè´¨æ¡çº¹åæåçèè´¨æ ¸å¿ã
å æ¤ï¼å¦æ循ç¯ä¸çLDL主è¦ç±å°èå¯é¢ç²ç»æï¼å å¿ç
çé£é©å°±ä¼åé«ã
é«çæ²¹ä¸é
¯è¡ççæ¬è´¨æ¯ä½å
sLDLå¢å ãæä½å¯åº¦èèç½ï¼VLDLï¼æ®ç²å/æä¹³ç³å¾®ç²æ®ç²å¢å ã
é«çæ²¹ä¸é
¯è¡çè´å¨èç²¥æ ·ç¡¬åè¡èå¼å¸¸ç临åºè¯æ®
èåºéãå¤åäºä»¶åæ®ä¼ä»æ±å¯¹ç¼ºè¡æ§ç¾ç
çé¿æå¹²é¢å并åæ表æï¼é«TGæ¯ä»æ±æ²»çç
人åçå¿è¡ç®¡äºä»¶çå±é©å ç´ ï¼æ示é«TGæ¯å¿è¡ç®¡å©çé£é©çéè¦å ç´ ä¹ä¸ãã2012è¡èç¸å
³æ§å¿è¡ç®¡å©çé£é©æ§å¶ä¸å½ä¸å®¶å
±è¯ãæåºï¼å³ä½¿ä»æ±æ²»ç使LDL-Cå¾å°æä½³æ§å¶ï¼<1.8mmol/Lï¼70mg/dlï¼ï¼é«TGï¼â¥2.26mmol/Lï¼200mg/dlï¼çæ£è
åç主è¦å¿è¡ç®¡äºä»¶çé£é©ä»è¾TG<2.26mmol/Lçæ£è
å¢å 27ï¼
ãå æ¤ï¼ä»æ±æ¶ä»£çç
人ä»å©çè¾é«å¿è¡ç®¡äºä»¶é£é©ï¼TGæ°´å¹³åé«æ¯å
¶éè¦å ç´ ä¹ä¸ã
Omega-3èèªé
¸ä¸»è¦å
æ¬äºå碳äºç¯é
¸ï¼EPAï¼åäºåäºç¢³å·±ç¯é
¸ï¼DHAï¼ï¼ä¸¤è
为深海鱼油ç主è¦æåãOmega-3èèªé
¸éè¿è°èVLDLåä¹³ç³å¾®ç²ä»£è°¢éä½è¡æ¸
TGæ°´å¹³ï¼å¹¶æ轻度åé«HDL-Cæ°´å¹³çä½ç¨ãå
¶ææä¸ä½¿ç¨çåéååºç¡TGæ°´å¹³æå
³ãå½è¡TGæ£å¸¸æ¶è¯¥è¯å ä¹æ²¡æéèä½ç¨ï¼è¥è¡TG>2.26mmol/Lï¼åºç¨Omega-3èèªé
¸ï¼4g/dï¼æ³¨ï¼è¿éçæå°çåæé«çº¯åº¦Omega-3鱼油ï¼æ²»çå¯ä½¿TGéä½30ï¼
ã该è¯å¯ä¸è´ç¹ç±»æä»æ±ç±»åç¨ãOmega-3çä¸è¯ååºå°ï¼èåæ§è¯å¥½ã
é«çº¯åº¦Omega-3鱼油éTGç临åºè¯æ®
临åºç 究ä¸ï¼
ç¾å½çLouisvilleå¨èç²¥æ ·ç¡¬åå代谢ç 究ä¸å¿å¨ä¸é¡¹å
³äº90% omega-3ä¹é
¯ï¼ä»¥ä¸ç®ç§°90% Omega-3ï¼+è¾ä¼ä»æ±ç»åæ²»çï¼COMBOSï¼çæ©å±æ§ç 究ä¸ï¼å¯¹90% Omega-3é
åè¾ä¼ä»æ±å
±å使ç¨çé¿æçæåå®å
¨æ§è¿è¡äºè¯ä¼°ã
æ¤ç 究å表å¨2010å¹´çCurrent Medical Research & Opinionï¼Vol. 26, No. 4, 2010, 907â915
ç 究对象åæ¹æ³
COMBOSç 究æåçåè¯è
ï¼ä¸ºè¿ç»ä½¿ç¨8å¨ä»æ±æ²»çåï¼LDL-Cæ°´å¹³ä¸é«äºNCEP ATP IIIæ²»çç®æ 10%ï¼ä½200 mg/dL<TGï¼500 mg/dLï¼2.26 mmol/L<TGï¼5.64 mmol/L)ãåè¯è
们被éæºåé
è³åç 究ç»ï¼è¿è¡ç¬¬ä¸é¶æ®µçç 究ã该é¶æ®µï¼åè¯è
é¤ç»§ç»æ¥åä»æ±çæ²»çå¤ï¼è¿åå«åæ¥åæç»8å¨90% omega-3æ¯æ¥ 4gçæ²»çæç¸ååéçå®æ
°åæ²»çãå¯æå®æä¸è¿°æ²»ççæ£è
ææèµæ ¼åä¸ä¸é¡¹é¿è¾¾ä¸¤å¹´çæ©å±æ§ç 究ã
å¨æ¤æ©å±æ§ç 究ä¸ï¼æ¾å¨ä¸ä¸é¶æ®µç 究ä¸æ¥åå®æ
°å+è¾ä¼ä»æ±æ²»ççæ£è
ç°å¨è½¬å为æ¥å90% Omega-3+è¾ä¼ä»æ±æ²»çï¼â转åè
,Switchersâï¼ï¼èæ¾ç»å¨åä¸é¶æ®µç 究ä¸æ¥å90% Omega-3+è¾ä¼ä»æ±æ²»ççæ£è
å¨æ©å±æ§ç 究é¶æ®µå继ç»ä½¿ç¨è¯¥çæ³ï¼âæªè½¬åè
,Non-switchersâï¼ã
ç 究ç»æåç»è®º
æ©å±æ§ç 究è¿è¡äº4ã12ã24æåçè¡èæ£æµæ¥å
a:转åè
ï¼Switchersï¼ä¸æªè½¬åè
(Non-switchers)ä¹é´çæ¯è¾
b:åä½ç转åï¼ä»mg/dL å° mmol/L,
å¨ç¬¬ä¸é¶æ®µçç 究ç»æåï¼æªè½¬åç»çNon-HDL-Cä¸è½¬åç»ç¸æ¯ä¸éæ´ææ¾ï¼æªè½¬åç»ï¼136.6å°126.6mg/Dl;转åç»ï¼143å°140mg/dLï¼ãå¨ç 究ç第äºé¶æ®µåæ©å±æ§ç 究ä¸ï¼ææåè¯è
çnon-HDL-Cå¨4个æã12个æå24个æååå«ä¸éäº-8.3%, -7.3%, -8.9%, è转åç»ç±äºè¯¥é¶æ®µç 究å¼å§æ¶ï¼å¹³ånon-HDL-CãTGçé«äºæªè½¬åç»ï¼å æ¤å¨æ¥åomega-3çæ²»çåï¼ä¸éå¹
度ææ¾æ´é«ãä»é¿è¿æ¥çï¼90%Omega-3ä¹é
¯å¯¹äºè¡èå¼å¸¸çæ£è
ææç»éä½non-HDL-CåTGçä½ç¨ï¼ä¸åºæ¬æ²¡æä¸è¯ååºãç±æ¤å¯ç¥ï¼å¨ä»æ±åºç¡ä¸èç¨omega-3对äºå¿è¡ç®¡æ®ä½é£é©æé常è¯å¥½çæ§å¶ä½ç¨ã
临åºç 究äºï¼
ç±Michael H. Davidsonå士çé¢çå¢éå¨ç¾å½èå å¥ã纽约çå°çå»å¦ä¸å¿å±å¼äºå
³äºOemga-3èç¨è¾ä¼ä»æ±æ²»çé«çæ²¹ä¸é
¯è¡çç临åºç 究ã
æ¤ç 究çç»æå表å¨Clinical Therapeutics, 2007,29(7):1354-1367.
ç 究对象åæ¹æ³
该ç 究æ¯ä¸é¡¹å¤ä¸å¿ãéæºãåç²ãå®æ
°å对ç
§çå¹³è¡å¯¹ç
§ç 究ã254ååè¯è
å¨ç 究å¼å§ååå·²æ¥åäºè¶
è¿8å¨çä»æ±ç±»è¯ç©ç稳å®æ²»çï¼å
¶å¹³å空è
¹TGæ°´å¹³ä»äº200 mg/dLä¸500 mg/dLä¹é´ï¼ä¸ä½å¯åº¦èèç½èåºéæ°´å¹³ç¥é«äºï¼ä¸è¶
è¿10%ï¼NCEP ATP IIIçç®æ å¼ãæ¬ç 究æ¹æ¡ä¸ï¼æå8å¨åè¯è
éæ¥åå¼æ¾æ ç¾å¼çè¾ä¼ä»æ±æ²»çï¼40mg/æ¥ï¼å¹¶éµå¾ªè³é£å»ºè®®ï¼éå8å¨å°éæºæ¥ååç²90% Omega-3ä¹é
¯ï¼4g/æ¥ï¼+è¾ä¼ä»æ±ï¼40mg/æ¥ï¼æ²»çæå®æ
°å+è¾ä¼ä»æ±ï¼40mg/æ¥ï¼æ²»çã对主è¦ç»æçæµé主è¦ä¾æ®é-HDL-Cä»åºçº¿æ°´å¹³èµ·è³æ²»çç»ææ¶ç¾åæ¯åççååã
ç 究ç»æåç»è®º
è³æ²»çç»ææ¶ï¼èç¨90% Omega-3ç 究ç»ç¸å¯¹å®æ
°åç»ï¼çæ²¹ä¸é
¯å¹³åä¸é29.5%ï¼éçæ²¹ä¸é
¯ææ为å®æ
°åç»ç4.6åï¼éä½æä½å¯åº¦èèç½ææ为å®æ
°åç»3.8åï¼æ´ä½è¡èæ§å¶æ
åµç±äºå®æ
°åç»ã
åè§èç¨çå®å
¨æ§ææ ï¼ä¸¤ç»é´åæ æ¾èå·®å¼ï¼è¿ç±»ä¸è¯äºä»¶å
æ¬é¼»å½ç(4 [3.3%])ãä¸å¼å¸éææ(4 [3.3%])ãè
¹æ³»(3 [2.5%])åæ¶åä¸è¯(3 [2.5%])ãåç»ä¹é´ä¸è¯äºä»¶çåçé¢ç并æ æ¾èå·®å¼ãä¸é¾çåºï¼è¾ä¼ä»æ±èç¨90%Omega-3è½æ´ææå®å
¨å¹¶ä¸å
¨é¢æ§å¶è¡èæ
åµã
æ¥æºï¼
Current Medical Research & Opinionï¼Vol. 26, No. 4, 2010, 907â915 & Clinical Therapeutics, 2007,29(7):1354-1367.
温馨提示:答案为网友推荐,仅供参考